Induction and mechanism of apoptotic cell death by propofol in HL-60 cells

Acta Anaesthesiologica Scandinavica

Volumn 46, Issue 9, 2002, Pages 1068-1074

  Tsuchiya, Masahiko ^a   Asada, A ^b   Arita, K ^b   Utsumi, T ^b   Yoshida, T ^b   Sato, E F ^b   Utsumi, K ^b   Inoue, M ^b  

^a Department of Anesthesiology and Intensive Care Medicine ^*  (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antioxidant; Apoptosis; Bid; Caspase; Cytochrome c; HL 60 cells; Mitochondria; Propofol

Indexed keywords

CASPASE; CYTOCHROME C; DNA FRAGMENT; PROPOFOL; PROTEIN BCL 2; PROTEIN KINASE C;

ANESTHESIA MECHANISM; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL GROWTH; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY;

ANESTHETICS, INTRAVENOUS; ANTIOXIDANTS; APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CARRIER PROTEINS; CASPASES; CELL DIVISION; CYTOCHROME C GROUP; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HL-60 CELLS; HUMANS; PEPTIDE FRAGMENTS; PROPOFOL; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0036785266     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2002.460903.x     Document Type: Article

References (40)

1. Zimmermann KC, Bonzon C, Green DR. The machinery of programmed cell death. Pharmacol Ther 2001: 92: 57-70.
2. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extract: requirement for dATP and cytochrome c. Cell 1996: 86: 147-157.
3. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis and its inhibitor ICAD. Nature 1998: 391: 43-50.
4. Nagata S. Apoptosis by death factor. Cell 1997: 88: 355-365.
5. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci 1996: 93: 2239-2244.
6. Arita K, Utsumi T, Kato A, Kanno T, Kabuchi H, Ihoue B et al. Mechanism of dibucaine-induced apoptosis in promyelocytic leukemia cells (HL-60). Biochem Pharmacol 2000: 60: 905-915.
7. Tsuchiya M, Asada A, Maeda K, Ueda Y, Sato EF, Shindo M et al. Propofol versus midazolam regarding their antioxidant activities. Am J Respir Crit Care Med 2001: 163: 26-31.
8. Tsuchiya M, Asada A, Kasahara E, Sato EF, Shindo M, Inoue M. Antioxidant protection of propofol and its recycling in erythrocyte membranes. Am J Respir Crit Care Med 2002: 165: 54-60.
9. Hemmings Jr. HC, Adamo AIB. Effects of halothane and propofol on purified brain protein kinase C activation. Anesthesiology 1994: 81: 147-155.
10. Satoh K, Ida Y, Hosaka M, Arakawa H, Kaeda M, Ishihara M et al. Induction of apoptosis by cooperative action of vitamins C and E. Anticancer Res 1998: 18: 4371-4376.
11. YuW, Simmons-Menchaca M, Gapor A, Sanders BG, Kline K. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr Cancer 1999: 33: 26-32.
12. Palomba L, Sestili P, Cantoni O. The antioxidant butylated hydroxytoluene induces apoptosis in human U937 cells: the role of hydrogen peroxide and altered redox state. Free Rad Res 1999: 31: 93-101.
13. Franklin RA, McCubrey JA. Kinases. positive and negative regulators of apoptosis. Leukemia 2000: 14: 2019-2034.
14. Olney JW, Farber NB, Wozniak DF, Jevtovic-Todorovic V, Ikonomidou C. Environmental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain. Environ Health Perspect 2000: 108 (Suppl. 3): 383-388.
15. Sagara Y, Hendler S, Khoh-Reiter S, Gillenwater G, Carlo D, Schubert D et al. Propofol hemisuccinate protects neuronal cells from oxidative injury. J Neurochem 1999: 73: 2524-2530.
16. Sendo F, Tsuchida H, Takeda Y, Gon S, Takei H, Kato T et al. Regulation of neutrophil apoptosis - its biological significance in inflammation and the immune response. Hum Cell 1996: 9: 215-222.
17. Schuurman HJ, Van Loveren H, Rozing J, Vos JG. Chemicals trophic for the thymus: risk for immunodeficiency and autoimmunity. Int J Immunopharmacol 1992: 14: 369-375.
18. Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 2001: 16: 83-96.
19. Delogu G, Moretti S, Famularo G, Antonucci C, Signore L, Marcellini S et al. Circulating neutrophils exhibit enhanced apoptosis associated with mitochondrial dysfunctions after surgery under general anaesthesia. Acta Anaesthesiol Scand 2001: 45: 87-94.
20. Fanning NF, Porter J, Shorten GD, Kirwan WO, Bouchier-Hayes D, Gotter TG et al. Inhibition of neutrophil apoptosis after elective surgery. Surgery 1999: 126: 527-534.
21. Ishii Y, Hori Y, Sakai S, Honma Y. Control of differentiation and apoptosis of human myeloid leukemia cells by cytokinins and cytokinin nucleosides, plant redifferentiation-inducing hormones. Cell Growth Differ 2002: 13: 19-26.
22. Yabuki M, Tsutsui K, Horton AA, Yoshioka T, Utsumi K. Caspase activation and cytochrome c release during HL-60 cell apoptosis induced by a nitric oxide donor. Free Radic Res 2000: 32: 507-514.
23. Lowry O, Rosebrough N, Farr A, Randall R. Protein measurement with the Folin phenol reagent. J Biol Chem 1951: 193: 265-275.
24. Charrad RS, Gadhoum Z, Qi J, Glachant A, Allouche M, Jocmin C et al. Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood 2002: 99: 290-299.
25. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Ann Rev Cell Dev Biol 1999: 15: 269-290.
26. Nishikawa M, Sato EF, Kuroki T, Utsumi K, Inoue M. Macrophage-derived nitric oxide induces apoptosis of rat hepatoma cells in vivo. Hepatology 1998: 28: 1474-1480.
27. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998: 281: 1309-1312.
28. Kaufmann SH, Hengartner MO. Programmed cell death: alive and well in the new millennium. Trends Cell Biol 2001: 11: 526-534.
29. Tsuchiya M, Kagan VE, Freisleben HJ, Manabe M, Packer L. Antioxidant activity of alpha-tocopherol, beta-carotene, and ubiquinol in membranes: cis-parinaric acid-incorporated liposomes. Meth Enzymol 1994: 234: 371-383.
30. Riu PL, Riu G, Testa C, Mulas M, Caria MA, Mameli O et al. Disposition of propofol between red blood cells, plasma, brain and cerebrospinal fluid in rabbits. Eur J Anaesthesiol 2000: 17: 18-22.
31. Fanning NF, Kell MR, Shorten GD, Kirwan WO, Bouchier-Hayes D, Gotter TG et al. Circulating granulocyte macrophage colony-stimulating factor in plasma of patients with the systemic inflammatory response syndrome delays neutrophil apoptosis through inhibition of spontaneous reactive oxygen species generation. Shock 1999: 11: 167-174.
32. Ertel W, Keel M, Infanger M, Ungethum U, Steckholzer U, Trentz O. Circulating mediators in serum of injured patients with septic complications inhibit neutrophil apoptosis through up-regulation of protein-tyrosine phosphorylatin. J Trauma 1998: 44: 767-776.
33. Palmblad J, Papadaki HA, Eliopoulos G. Acute and chronic neutropenias. What is new? J Intern Med 2001: 250: 476-491.
34. Pitrak DL. Apoptosis and its role in neutrophil dysfunction in AIDS. Oncologist 1997: 2: 121-124.
35. Grutter MG. Caspases: key players in programmed cell death. Curr Opin Struct Biol 2000: 10: 649-655.
36. Chang HY, Yang X. Proteases for cell suicide: functions and regulation of caspases. Microbiol Mol Biol Rev 2000: 64: 821-846.
37. Blakey SA, Hixson-Wallace JA. Clinical significance of rare and benign side effects, propofol and green urine. Pharmacotherapy 2000: 20: 1120-1122.
38. Cray SH, Robinson BH, Cox PN. Lactic acidemia and bradyarrhythmia in a child sedated with propofol. Crit Care Med 1998: 26: 2087-2092.
39. Islander G, Vinge E. Severe neuroexcitatory symptoms after anaesthesia - with focus on propofol anaesthesia. Acta Anaesthesiol Scand 2000: 44: 144-149.
40. Morishita S, Sato EF, Takahashi K, Manabe M, Inoue M. Insulin-induced hypoglycemia elicits thymocyte apoptosis in the rat. Diabetes Res Clin Pract 1998: 40: 1-7.